» Articles » PMID: 26069211

Reversible Transformation and De-differentiation of Human Cells Derived from Induced Pluripotent Stem Cell Teratomas

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2015 Jun 13
PMID 26069211
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We first aimed to generate transformed cell lines from a human induced pluripotent stem cell (hiPSC)-teratoma, and then examined the tumorigenic risks of the differentiated cells from hiPSC explant, because hiPSC-derivatives give rise to tumors in immune-deficient mice when transplanted. The colonies isolated from sparse cultures of hiPSC-teratoma cells expressed NANOG and OCT3/4 strongly, and telomerase reverse transcriptase (TERT) weakly. However, soft agar assay demonstrated that only one of them generated colonies in the gel, though hiPSCs, hTERT-transfected immortal cells, and its oncogene-transfected cells did not form any colonies. Furthermore, none of colonies isolated from the soft agar gel on primary culture (passage 0) of teratoma cells, expressed NANOG and OCT3/4 in the expanded cultures. The second soft agar assay on the colony-derived cells was unexpectedly negative. The cumulative growth curve, telomere shortening, and senescence-associated β-galactosidase (SA β-gal) staining confirmed the mortality of these cells, suggesting their reversible transformation. By using medium for embryonic stem cell (ESC medium) after MCDB 131 (MCDB) medium, the differentiated culture cells derived from hiPSC-teratoma converted into the cells expressing undifferentiated marker proteins, which lost afterwords even in ESC medium with feeder SNL76/7. The reversibility of transformation and de-differentiation suggest that tumorigenic risks of differentiated cells arise when they are exposed to suitable niches in vivo. Thus, removal of only the undifferentiated cells from iPSC-derivatives before transplantation does not solve the problem. Elucidation of mechanisms of reversibility and control of epigenetic changes is discussed as a safety bottleneck for hiPSC therapy.

Citing Articles

Telomeres and Telomerase in the Control of Stem Cells.

Lupatov A, Yarygin K Biomedicines. 2022; 10(10).

PMID: 36289597 PMC: 9598777. DOI: 10.3390/biomedicines10102335.


Grafted human induced pluripotent stem cells improve the outcome of spinal cord injury: modulation of the lesion microenvironment.

Bellak T, Fekecs Z, Torok D, Tancos Z, Nemes C, Tezsla Z Sci Rep. 2020; 10(1):22414.

PMID: 33376249 PMC: 7772333. DOI: 10.1038/s41598-020-79846-2.


Extra-telomeric impact of telomeres: Emerging molecular connections in pluripotency or stemness.

Vinayagamurthy S, Ganguly A, Chowdhury S J Biol Chem. 2020; 295(30):10245-10254.

PMID: 32444498 PMC: 7383370. DOI: 10.1074/jbc.REV119.009710.


CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells.

Zheng Z, Li C, Ha P, Chang G, Yang P, Zhang X J Clin Invest. 2019; 129(8):3236-3251.

PMID: 31305260 PMC: 6668700. DOI: 10.1172/JCI125015.


Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.

Adamiak M, Cheng G, Bobis-Wozowicz S, Zhao L, Kedracka-Krok S, Samanta A Circ Res. 2017; 122(2):296-309.

PMID: 29118058 PMC: 5775034. DOI: 10.1161/CIRCRESAHA.117.311769.


References
1.
Kamada M, Mitsui Y, Kumazaki T, Kawahara Y, Matsuo T, Takahashi T . Tumorigenic risk of human induced pluripotent stem cell explants cultured on mouse SNL76/7 feeder cells. Biochem Biophys Res Commun. 2014; 453(3):668-73. DOI: 10.1016/j.bbrc.2014.10.009. View

2.
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

3.
Yu J, Vodyanik M, Smuga-Otto K, Antosiewicz-Bourget J, Frane J, Tian S . Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318(5858):1917-20. DOI: 10.1126/science.1151526. View

4.
Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S . Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008; 322(5903):949-53. DOI: 10.1126/science.1164270. View

5.
Kim D, Kim C, Moon J, Chung Y, Chang M, Han B . Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009; 4(6):472-6. PMC: 2705327. DOI: 10.1016/j.stem.2009.05.005. View